94 related articles for article (PubMed ID: 16944508)
1. A physiologically based pharmacokinetic model for endosulfan in the male Sprague-Dawley rats.
Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Sugimoto M; Yoneda M
Environ Toxicol; 2006 Oct; 21(5):464-78. PubMed ID: 16944508
[TBL] [Abstract][Full Text] [Related]
2. Toxicokinetics of 14C-endosulfan in male Sprague-Dawley rats following oral administration of single or repeated doses.
Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Sugimoto M; Yoneda M
Environ Toxicol; 2005 Oct; 20(5):533-41. PubMed ID: 16161119
[TBL] [Abstract][Full Text] [Related]
3. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
[TBL] [Abstract][Full Text] [Related]
4. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
[TBL] [Abstract][Full Text] [Related]
5. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
[TBL] [Abstract][Full Text] [Related]
6. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
7. A physiologically based pharmacokinetic/pharmacodynamic model for carbofuran in Sprague-Dawley rats using the exposure-related dose estimating model.
Zhang X; Tsang AM; Okino MS; Power FW; Knaak JB; Harrison LS; Dary CC
Toxicol Sci; 2007 Dec; 100(2):345-59. PubMed ID: 17804862
[TBL] [Abstract][Full Text] [Related]
8. Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition.
Nong A; Tan YM; Krolski ME; Wang J; Lunchick C; Conolly RB; Clewell HJ
J Toxicol Environ Health A; 2008; 71(20):1363-81. PubMed ID: 18704829
[TBL] [Abstract][Full Text] [Related]
9. A physiologically based pharmacokinetic model for valnemulin in rats and extrapolation to pigs.
Yuan LG; Luo XY; Zhu LX; Wang R; Liu YH
J Vet Pharmacol Ther; 2011 Jun; 34(3):224-31. PubMed ID: 20950354
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon.
Poet TS; Kousba AA; Dennison SL; Timchalk C
Neurotoxicology; 2004 Dec; 25(6):1013-30. PubMed ID: 15474619
[TBL] [Abstract][Full Text] [Related]
11. Blood concentrations of acrylonitrile in humans after oral administration extrapolated from in vivo rat pharmacokinetics, in vitro human metabolism, and physiologically based pharmacokinetic modeling.
Takano R; Murayama N; Horiuchi K; Kitajima M; Kumamoto M; Shono F; Yamazaki H
Regul Toxicol Pharmacol; 2010 Nov; 58(2):252-8. PubMed ID: 20600458
[TBL] [Abstract][Full Text] [Related]
12. Development of an in vitro blood-brain barrier model to study the effects of endosulfan on the permeability of tight junctions and a comparative study of the cytotoxic effects of endosulfan on rat and human glial and neuronal cell cultures.
Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Yoneda M
Environ Toxicol; 2006 Jun; 21(3):223-35. PubMed ID: 16646017
[TBL] [Abstract][Full Text] [Related]
13. Physiologically based pharmacokinetic models for the transport of trichloroethylene in adipose tissue.
Albanese RA; Banks HT; Evans MV; Potter LK
Bull Math Biol; 2002 Jan; 64(1):97-131. PubMed ID: 11868339
[TBL] [Abstract][Full Text] [Related]
14. An updated physiologically based pharmacokinetic model for hexachlorobenzene: incorporation of pathophysiological states following partial hepatectomy and hexachlorobenzene treatment.
Lu Y; Lohitnavy M; Reddy MB; Lohitnavy O; Ashley A; Yang RS
Toxicol Sci; 2006 May; 91(1):29-41. PubMed ID: 16481338
[TBL] [Abstract][Full Text] [Related]
15. A physiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species.
Sweeney RE; Langenberg JP; Maxwell DM
Arch Toxicol; 2006 Nov; 80(11):719-31. PubMed ID: 16718492
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based modeling of p-tert-octylphenol kinetics following intravenous, oral or subcutaneous exposure in male and female Sprague-Dawley rats.
Hamelin G; Haddad S; Krishnan K; Tardif R
J Appl Toxicol; 2010 Jul; 30(5):437-49. PubMed ID: 20186885
[TBL] [Abstract][Full Text] [Related]
17. Physiologically-based pharmacokinetic modeling of genistein in rats, Part I: Model development.
Schlosser PM; Borghoff SJ; Coldham NG; David JA; Ghosh SK
Risk Anal; 2006 Apr; 26(2):483-500. PubMed ID: 16573635
[TBL] [Abstract][Full Text] [Related]
18. Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice.
Ward KW; Blumenthal GM; Welsch F; Pollack GM
Toxicol Appl Pharmacol; 1997 Aug; 145(2):311-22. PubMed ID: 9266804
[TBL] [Abstract][Full Text] [Related]
19. A PBPK model for midazolam in four avian species.
Cortright KA; Wetzlich SE; Craigmill AL
J Vet Pharmacol Ther; 2009 Dec; 32(6):552-65. PubMed ID: 20444010
[TBL] [Abstract][Full Text] [Related]
20. Physiologically based pharmacokinetics of bisphenol A.
Shin BS; Kim CH; Jun YS; Kim DH; Lee BM; Yoon CH; Park EH; Lee KC; Han SY; Park KL; Kim HS; Yoo SD
J Toxicol Environ Health A; 2004 Dec; 67(23-24):1971-85. PubMed ID: 15513896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
